Posts Tagged ‘ACOR’

Weekend Review of Unusual Options Trading (ACOR, CAAS, GME, HK, S, TEVA, VVUS)

Each Saturday we usually try to do a review of some unusual options trading at the end of the week.  With Friday being expiration date, that can always mask some of the larger trades.  We tracked unusual options trading in shares of Acorda Therapeutics, Inc. (NASDAQ: ACOR), China Automotive Systems Inc. (NASDAQ: CAAS), GameStop Corp. [...]

Acorda Volume Goes Exponential Before Market Open (ACOR)

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is getting some of its lost mojo back.  The company’s fampridine-SR for multiple sclerosis was given a favorable FDA panel review yesterday in a 12-1 vote in support of a future marketing approval for the drug.  The stock was halted yesterday and FDA comments last week battered the stock.  This [...]

Acorda Options Worth Second Look (ACOR)

Acorda Therapeutics, Inc. (NASDAQ: ACOR) was covered already this morning for its significant price-volume alert.  Including teh after-hours session at 4:45 PM EST we saw some 14.54 million shares trade and the stock closed out down 21% at $17.52.  This volume is impressive even if the price drop is not, but there was also a [...]

Acorda Down Over 10% Ahead of FDA (ACOR)

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is getting hit hard this morning ahead of an expected FDA decision to make public the background material over Acorda’s Fampridine on or before October 12.  Shares are dowhn 11% at $19.86 on about 400,000 shares as of 8:20 AM EST.  Average volume is 450,000 shares and the 52-week trading [...]

Pre-Market Volume Spike: Acorda Therapeutics (ACOR)

Acorda Therapeutics (NASDAQ: ACOR) is seeing shares surge on active pre-market trading volume on news this Monday morning.  The company announced positive data from a second Phase III study of its Fampridine-SR as a treatment for patients’ walking abilities who suffer from multiple sclerosis. Acorda trades has an average daily volume of about about 570,000 [...]